Literature DB >> 26223196

A curable cause of hypertension: renal artery pseudoaneurysm.

Ibrahim Halil Altiparmak1, Muslihittin Emre Erkus2, Ozgur Gunebakmaz2, Yusuf Sezen2, Zekeriya Kaya2, Recep Demirbag2.   

Abstract

Renal artery aneurysms and pseudoaneurysms are rare vascular abnormalities. These anomalies, which are usually asymptomatic, may be associated with hypertension. Here, we present the successful treatment of a renal artery pseudoaneurysm in a patient with hypertension, with an overview of the literature.

Entities:  

Keywords:  Coil embolization; Hypertension; Pseudoaneurysm; Renal artery; Treatment

Mesh:

Year:  2015        PMID: 26223196     DOI: 10.1007/s00508-015-0822-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  5 in total

1.  Stent-assisted coil embolization of a wide-necked renal artery aneurysm.

Authors:  Bjoern Kitzing; John Vedelago; Nick Bajic; Grace Lai; Richard Waugh
Journal:  J Radiol Case Rep       Date:  2010-04-01

2.  Endovascular treatment of eight renal artery aneurysms.

Authors:  Amr Abdel-Kerim; Lucie Cassagnes; Agaicha Alfidja; Cristian Gageanu; Gregory Favrolt; Eric Dumousset; Anne Ravel; Louis Boyer; Pascal Chabrot
Journal:  Acta Radiol       Date:  2012-03-20       Impact factor: 1.990

3.  Renal aneurysms and pseudoaneurysms.

Authors:  Marco Cura; Fadi Elmerhi; Alejandro Bugnogne; Raul Palacios; Rajeev Suri; Timothy Dalsaso
Journal:  Clin Imaging       Date:  2011 Jan-Feb       Impact factor: 1.605

4.  Renal artery aneurysm in a hypertensive child treated by percutaneous coil embolization.

Authors:  Sevtap Gümüştaş; Ercüment Ciftçi; Zelal Bircan
Journal:  Pediatr Radiol       Date:  2010-02-10

Review 5.  Successful endovascular renal artery aneurysm exclusion using the Venture catheter and covered stent implantation: a case report and review of the literature.

Authors:  Tiziana Claudia Aranzulla; Antonio Colombo; Giuseppe Massimo Sangiorgi
Journal:  J Invasive Cardiol       Date:  2007-08       Impact factor: 2.022

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.